Skip to main content
. 2018 Feb 15;9(3):269. doi: 10.1038/s41419-018-0302-x

Fig. 5. The combined effect of simvastatin and sorafenib in HCC cells.

Fig. 5

a, b CCK8 assays were used to detect the effect of simvastatin combined with sorafenib (Raf inhibitor) on the proliferation in HepG2 and SMMC7721 HCC cells. c, d, Colony formation assays were used to detect the effect of simvastatin combined with sorafenib on the survival of HCC cells. e, f WB was used to examine the effect of combined treatment on the core effectors of downstream signaling